Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-24-005017

Options or other derivatives

  • Director acquired 20,594 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROOT JONATHAN D Director 2024-06-10 Grant or award · Stock Option (Right to Buy) +20,594 20,594 D: show line 1 in the form
Loading xslF345X05/primarydocument.xml…